1 completed, 1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Juerg Hafner: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream IMP2 (lidocaine-23%-tetracaine-7% gel), IMP1 (EMLA 5% cream) - Ulcus Cruris, Ecthyma | Phase 2 | Unknown | Juerg Hafner | 40 | 2023-06-01 | 2023-06-06 |
| Keratinocyte Skin Cancer Surgery in the Elderly, Aged 80 Years and Over, is Effective and Safe Postoperative Complication | Completed | Juerg Hafner | 345 | 2022-01-01 | 2024-10-30 |
Ecthyma (1) · Foot Ulcer (1) · Leg Ulcer (1) · Postoperative Complications (1) · Varicose Ulcer (1)
IGF2BP2 protein, human (1) · Lidocaine, Prilocaine Drug Combination (1) · signal peptide peptidase (1)
Switzerland (2)